DK144640C - Analogifremgangsmaade til fremstilling af 5-substituerede indan-2-karboxylsyrer eller farmaceutisk acceptable salte eller c1-6-alkylestere deraf - Google Patents
Analogifremgangsmaade til fremstilling af 5-substituerede indan-2-karboxylsyrer eller farmaceutisk acceptable salte eller c1-6-alkylestere derafInfo
- Publication number
- DK144640C DK144640C DK554677A DK554677A DK144640C DK 144640 C DK144640 C DK 144640C DK 554677 A DK554677 A DK 554677A DK 554677 A DK554677 A DK 554677A DK 144640 C DK144640 C DK 144640C
- Authority
- DK
- Denmark
- Prior art keywords
- alkylesters
- analogue
- preparation
- acceptable salts
- carboxylic acids
- Prior art date
Links
- -1 5-SUBSTITUTED INDAN-2-CARBOXYLIC Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7637574 | 1976-12-14 | ||
| FR7637574A FR2374032A2 (fr) | 1976-12-14 | 1976-12-14 | Nouveaux acides carboxyliques derives de l'indane |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK554677A DK554677A (da) | 1978-06-15 |
| DK144640B DK144640B (da) | 1982-04-26 |
| DK144640C true DK144640C (da) | 1982-10-04 |
Family
ID=9181028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK554677A DK144640C (da) | 1976-12-14 | 1977-12-13 | Analogifremgangsmaade til fremstilling af 5-substituerede indan-2-karboxylsyrer eller farmaceutisk acceptable salte eller c1-6-alkylestere deraf |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5373548A (fr) |
| AT (1) | AT355559B (fr) |
| AU (1) | AU515268B2 (fr) |
| BE (1) | BE861826R (fr) |
| CA (1) | CA1088554A (fr) |
| CH (1) | CH627728A5 (fr) |
| DD (1) | DD133323A6 (fr) |
| DE (1) | DE2753315A1 (fr) |
| DK (1) | DK144640C (fr) |
| ES (1) | ES465056A2 (fr) |
| FR (1) | FR2374032A2 (fr) |
| GB (1) | GB1584298A (fr) |
| HU (1) | HU177226B (fr) |
| IE (1) | IE46013B1 (fr) |
| IL (2) | IL60599A0 (fr) |
| MX (1) | MX4954E (fr) |
| NL (1) | NL7713876A (fr) |
| NO (1) | NO774285L (fr) |
| SE (1) | SE436740B (fr) |
| SU (1) | SU799646A3 (fr) |
| ZA (1) | ZA777438B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2801182A1 (fr) * | 2010-06-16 | 2011-12-22 | Metabolex, Inc. | Agonistes du recepteur gpr120 et leurs utilisations |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4980053A (fr) * | 1972-12-05 | 1974-08-02 | ||
| JPS5838416B2 (ja) * | 1974-05-31 | 1983-08-23 | 武田薬品工業株式会社 | カンジヨウカゴウブツノセイゾウホウ |
| JPS5335944B2 (fr) * | 1974-05-21 | 1978-09-29 |
-
1976
- 1976-12-14 FR FR7637574A patent/FR2374032A2/fr active Granted
-
1977
- 1977-11-30 DE DE19772753315 patent/DE2753315A1/de not_active Ceased
- 1977-12-12 GB GB51699/77A patent/GB1584298A/en not_active Expired
- 1977-12-13 SE SE7714110A patent/SE436740B/sv unknown
- 1977-12-13 MX MX776686U patent/MX4954E/es unknown
- 1977-12-13 DD DD7700202588A patent/DD133323A6/xx unknown
- 1977-12-13 DK DK554677A patent/DK144640C/da not_active IP Right Cessation
- 1977-12-13 NO NO774285A patent/NO774285L/no unknown
- 1977-12-13 IE IE2520/77A patent/IE46013B1/en unknown
- 1977-12-13 HU HU77LI316A patent/HU177226B/hu unknown
- 1977-12-14 AT AT892577A patent/AT355559B/de not_active IP Right Cessation
- 1977-12-14 ZA ZA00777438A patent/ZA777438B/xx unknown
- 1977-12-14 CH CH1541077A patent/CH627728A5/fr not_active IP Right Cessation
- 1977-12-14 ES ES465056A patent/ES465056A2/es not_active Expired
- 1977-12-14 BE BE183429A patent/BE861826R/fr not_active IP Right Cessation
- 1977-12-14 AU AU31530/77A patent/AU515268B2/en not_active Expired
- 1977-12-14 CA CA293,076A patent/CA1088554A/fr not_active Expired
- 1977-12-14 JP JP14943377A patent/JPS5373548A/ja active Pending
- 1977-12-14 NL NL7713876A patent/NL7713876A/xx not_active Application Discontinuation
-
1979
- 1979-04-06 SU SU792746906A patent/SU799646A3/ru active
-
1980
- 1980-07-15 IL IL60599A patent/IL60599A0/xx unknown
- 1980-07-15 IL IL60598A patent/IL60598A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2753315A1 (de) | 1978-06-15 |
| DK554677A (da) | 1978-06-15 |
| NO774285L (no) | 1978-06-15 |
| AT355559B (de) | 1980-03-10 |
| FR2374032A2 (fr) | 1978-07-13 |
| IL60598A0 (en) | 1980-09-16 |
| MX4954E (es) | 1983-01-13 |
| GB1584298A (en) | 1981-02-11 |
| DD133323A6 (de) | 1978-12-27 |
| BE861826R (fr) | 1978-06-14 |
| DK144640B (da) | 1982-04-26 |
| IL60599A0 (en) | 1980-09-16 |
| ZA777438B (en) | 1979-05-30 |
| JPS5373548A (en) | 1978-06-30 |
| SE7714110L (sv) | 1978-06-15 |
| CA1088554A (fr) | 1980-10-28 |
| IE46013L (en) | 1978-06-14 |
| SE436740B (sv) | 1985-01-21 |
| AU515268B2 (en) | 1981-03-26 |
| SU799646A3 (ru) | 1981-01-23 |
| CH627728A5 (en) | 1982-01-29 |
| AU3153077A (en) | 1979-06-21 |
| IE46013B1 (en) | 1983-01-26 |
| NL7713876A (nl) | 1978-06-16 |
| HU177226B (en) | 1981-08-28 |
| ATA892577A (de) | 1979-08-15 |
| ES465056A2 (es) | 1979-01-16 |
| FR2374032B2 (fr) | 1979-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK145339C (da) | Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf | |
| DK143275C (da) | Analogifremgangsmaade til fremstilling af 1-(3-dimethylaminopropyl)-phthalanderivater eller syreadditionssalte deraf | |
| DK150512C (da) | Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf | |
| DK145119C (da) | Analogifremgangsmaade til fremstilling af phenolethere eller syreadditionssalte deraf | |
| DK164545C (da) | Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf | |
| DK162714C (da) | Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf | |
| DK147362C (da) | Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf | |
| DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
| DK151331C (da) | Analogifremgangsmaade til fremstilling af 5-pyridinyl-2(1h)-pyridinon-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK149609C (da) | Analogifremgangsmaade til fremstilling af hydroxyamino-alkan- eller -alkenphosphonsyrederivater eller estere eller salte deraf | |
| DK145260C (da) | Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf | |
| DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
| DK149108C (da) | Analogi-fremgangsmaade til fremstilling af 5-alkoxyimidazo(1,2-a)qoinolin-2-carboxylsyrer eller estere eller kationiske salte deraf | |
| DK149569C (da) | Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK156301C (da) | Analogifremgangsmaade til fremstilling af oxy- eller oxosubstituerede phenoxy- eller phenylthio-azacycloalkaner eller deres syreadditionssalte | |
| DK154950C (da) | Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf | |
| DK147940C (da) | Analogifremgangsmaade til fremstilling af 4-substituerede thiazol-2-oxamsyrederivater eller salte eller estre deraf | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK158983C (da) | Analogifremgangsmaade til fremstilling af benzoylpiperazinestre eller syreadditionssalte deraf | |
| DK146281C (da) | Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf | |
| DK149841C (da) | Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK145263C (da) | Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
| DK149077C (da) | Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK149611C (da) | Analogifremgangsmaade til fremstilling af trh-analoge tripeptidamider eller terapeutisk acceptable komplexer eller salte deraf | |
| DK143278C (da) | Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |